Haley Deamond
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haley Deamond has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Alfredo Ribeiro-Da-Silva
McGill University, Department of Pharmacology and Therapeutics, Montreal, Canada; Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada
3 shared publications - Jeffrey S. Mogil
Department of Psychology, McGill University, Montreal, QC, Canada.
3 shared publications - Luda Diatchenko
Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada; Department of Anesthesia, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC, Canada
3 shared publications - Marc Parisien
Alan Edwards Centre for Research on Pain, McGill University, Montreal, QC, Canada; Department of Anesthesia, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada; Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, QC, Canada
3 shared publications - Arkady Khoutorsky
McGill University
2 shared publications - Behrang Sharif
Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada
2 shared publications
Latest Publications
- Open Access
- 11 March 2026
- Published by Wiley in Head & Neck
- Vol. 48 (8) , 2120-2134
Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life
Background: Quality of life (QoL) in head and neck cancer (HNC) is influenced by complex biopsychosocial factors, yet few longitudinal studies have examined these relationships immediately post‐treatment. Methods: In this prospective study, 232 patients newly diagnosed with primary HNC completed psychometric assessments, clinical interviews, and medical chart reviews at baseline, 3, 6, and 12 months. QoL was measured using the Functional Assessment of Cancer Therapy–HNC module. A two‐step cluster analysis identified distinct biopsychosocial subgroups, and mixed ANOVA tested QoL trajectories across time. Results: Three clusters emerged: (1) early‐stage disease with low treatment intensity; (2) high psychological burden and (3) advanced disease with high treatment intensity. These were associated with highest QoL, persistently lowest QoL ( p < 0.001), and intermediate QoL that improved over time respectively. Conclusions: Psychological distress exerted a stronger influence on QoL than medical burden. Early identification and intervention for psychosocial risk factors may optimize recovery in HNC patients.
- 11 March 2026
- Published by Wiley in Head & Neck
- Vol. 48 (8) , 2120-2134
Open AccessToward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life
Background: Quality of life (QoL) in head and neck cancer (HNC) is influenced by complex biopsychosocial factors, yet few longitudinal studies have examined these relationships immediately post‐treatment. Methods: In this prospective study, 232 patients newly diagnosed with primary HNC completed psychometric assessments, clinical interviews, and medical chart reviews at baseline, 3, 6, and 12 months. QoL was measured using the Functional Assessment of Cancer Therapy–HNC module. A two‐step cluster analysis identified distinct biopsychosocial subgroups, and mixed ANOVA tested QoL trajectories across time. Results: Three clusters emerged: (1) early‐stage disease with low treatment intensity; (2) high psychological burden and (3) advanced disease with high treatment intensity. These were associated with highest QoL, persistently lowest QoL ( p < 0.001), and intermediate QoL that improved over time respectively. Conclusions: Psychological distress exerted a stronger influence on QoL than medical burden. Early identification and intervention for psychosocial risk factors may optimize recovery in HNC patients.
- Top Cited PapersOpen Access
- 17 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Targeting C1q prevents microglia-mediated synaptic removal in neuropathic pain
Activation of spinal microglia following peripheral nerve injury is a central component of neuropathic pain pathology. While the contributions of microglia-mediated immune and neurotrophic signalling have been well-characterized, the phagocytic and synaptic pruning roles of microglia in neuropathic pain remain less understood. Here, we show that peripheral nerve injury induces microglial engulfment of dorsal horn synapses, leading to a preferential loss of inhibitory synapses and a shift in the balance between inhibitory and excitatory synapse density. This synapse removal is dependent on the microglial complement-mediated synapse pruning pathway, as mice deficient in complement C3 and C4 do not exhibit synapse elimination. Furthermore, pharmacological inhibition of the complement protein C1q prevents dorsal horn inhibitory synapse loss and attenuates neuropathic pain. Therefore, these results demonstrate that the complement pathway promotes persistent pain hypersensitivity via microglia-mediated engulfment of dorsal horn synapses in the spinal cord, revealing C1q as a therapeutic target in neuropathic pain.
- 17 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Top Cited PapersOpen AccessTargeting C1q prevents microglia-mediated synaptic removal in neuropathic pain
Activation of spinal microglia following peripheral nerve injury is a central component of neuropathic pain pathology. While the contributions of microglia-mediated immune and neurotrophic signalling have been well-characterized, the phagocytic and synaptic pruning roles of microglia in neuropathic pain remain less understood. Here, we show that peripheral nerve injury induces microglial engulfment of dorsal horn synapses, leading to a preferential loss of inhibitory synapses and a shift in the balance between inhibitory and excitatory synapse density. This synapse removal is dependent on the microglial complement-mediated synapse pruning pathway, as mice deficient in complement C3 and C4 do not exhibit synapse elimination. Furthermore, pharmacological inhibition of the complement protein C1q prevents dorsal horn inhibitory synapse loss and attenuates neuropathic pain. Therefore, these results demonstrate that the complement pathway promotes persistent pain hypersensitivity via microglia-mediated engulfment of dorsal horn synapses in the spinal cord, revealing C1q as a therapeutic target in neuropathic pain.
- Top Cited PapersOpen Access
- 11 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Single-cell RNA sequencing reveals time- and sex-specific responses of mouse spinal cord microglia to peripheral nerve injury and links ApoE to chronic pain
Activation of microglia in the spinal cord following peripheral nerve injury is critical for the development of long-lasting pain hypersensitivity. However, it remains unclear whether distinct microglia subpopulations or states contribute to different stages of pain development and maintenance. Using single-cell RNA-sequencing, we show that peripheral nerve injury induces the generation of a male-specific inflammatory microglia subtype, and demonstrate increased proliferation of microglia in male as compared to female mice. We also show time- and sex-specific transcriptional changes in different microglial subpopulations following peripheral nerve injury. Apolipoprotein E (Apoe) is the top upregulated gene in spinal cord microglia at chronic time points after peripheral nerve injury in mice. Furthermore, polymorphisms in the APOE gene in humans are associated with chronic pain. Single-cell RNA sequencing analysis of human spinal cord microglia reveals a subpopulation with a disease-related transcriptional signature. Our data provide a detailed analysis of transcriptional states of mouse and human spinal cord microglia, and identify a link between ApoE and chronic pain in humans.
- 11 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Top Cited PapersOpen AccessSingle-cell RNA sequencing reveals time- and sex-specific responses of mouse spinal cord microglia to peripheral nerve injury and links ApoE to chronic pain
Activation of microglia in the spinal cord following peripheral nerve injury is critical for the development of long-lasting pain hypersensitivity. However, it remains unclear whether distinct microglia subpopulations or states contribute to different stages of pain development and maintenance. Using single-cell RNA-sequencing, we show that peripheral nerve injury induces the generation of a male-specific inflammatory microglia subtype, and demonstrate increased proliferation of microglia in male as compared to female mice. We also show time- and sex-specific transcriptional changes in different microglial subpopulations following peripheral nerve injury. Apolipoprotein E (Apoe) is the top upregulated gene in spinal cord microglia at chronic time points after peripheral nerve injury in mice. Furthermore, polymorphisms in the APOE gene in humans are associated with chronic pain. Single-cell RNA sequencing analysis of human spinal cord microglia reveals a subpopulation with a disease-related transcriptional signature. Our data provide a detailed analysis of transcriptional states of mouse and human spinal cord microglia, and identify a link between ApoE and chronic pain in humans.
- Open Access
- 15 November 2021
- Published by Springer Nature in Research Square
Complement protein C1q is a therapeutic target for neuropathic pain
Activation of spinal microglia following peripheral nerve injury is a central component of neuropathic pain pathology. While the contributions of microglia-mediated immune and neurotrophic signalling have been well-characterized, the phagocytic and synaptic pruning roles of microglia in neuropathic pain remain unknown. Here, we show that peripheral nerve injury induces engulfment of dorsal horn synapses by microglia, leading to a preferential loss of inhibitory synapses. This synapse removal is dependent on the microglial complement-mediated synapse pruning pathway, as mice deficient in complement C3 do not exhibit synapse elimination. Furthermore, pharmacological inhibition of the complement protein C1q prevents dorsal horn inhibitory synapse loss and attenuates neuropathic pain. Thus, these results demonstrate that the complement pathway promotes persistent pain hypersensitivity via microglia-mediated engulfment and loss of inhibitory synapses in the dorsal horn of the spinal cord, revealing C1q as a novel therapeutic target in neuropathic pain.
- 15 November 2021
- Published by Springer Nature in Research Square
Open AccessComplement protein C1q is a therapeutic target for neuropathic pain
Activation of spinal microglia following peripheral nerve injury is a central component of neuropathic pain pathology. While the contributions of microglia-mediated immune and neurotrophic signalling have been well-characterized, the phagocytic and synaptic pruning roles of microglia in neuropathic pain remain unknown. Here, we show that peripheral nerve injury induces engulfment of dorsal horn synapses by microglia, leading to a preferential loss of inhibitory synapses. This synapse removal is dependent on the microglial complement-mediated synapse pruning pathway, as mice deficient in complement C3 do not exhibit synapse elimination. Furthermore, pharmacological inhibition of the complement protein C1q prevents dorsal horn inhibitory synapse loss and attenuates neuropathic pain. Thus, these results demonstrate that the complement pathway promotes persistent pain hypersensitivity via microglia-mediated engulfment and loss of inhibitory synapses in the dorsal horn of the spinal cord, revealing C1q as a novel therapeutic target in neuropathic pain.